Xtant Medical Overview
- Year Founded
-
1998
- Status
-
Public
- Employees
-
215
- Stock Symbol
-
XTNT
- Investments
-
7
- Share Price
-
$0.60
- (As of Monday Closing)
Xtant Medical General Information
Description
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the US.
Contact Information
Website
www.xtantmedical.comCorporate Office
- 664 Cruiser Lane
- Belgrade, MT 59714
- United States
Corporate Office
- 664 Cruiser Lane
- Belgrade, MT 59714
- United States
Xtant Medical Timeline
Xtant Medical Stock Performance
(As of Monday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.60 | $0.58 | $0.51 - $1.45 | $82.6M | 138M | 79.8K | -$0.02 |
Xtant Medical Financials Summary
|
In Thousands, USD |
TTM 30-Jun-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 | FY 2021 31-Dec-2021 |
|---|---|---|---|---|
| EV | 106,280 | 161,391 | 68,828 | 47,151 |
| Revenue | 110,943 | 91,303 | 57,969 | 55,263 |
| EBITDA | 2,292 | 4,952 | (5,455) | (2,454) |
| Net Income | (3,333) | 660 | (8,485) | (4,849) |
| Total Assets | 95,578 | 92,612 | 60,229 | 54,692 |
| Total Debt | 34,988 | 23,559 | 17,072 | 16,845 |
Xtant Medical Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Xtant Medical Comparisons
Industry
Financing
Details
000000
0000 0
Xtant Medical Competitors (14)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Orthofix International | Formerly PE-Backed | Lewisville, TX | 0000 | 00000 | 000000000 00 | 00000 |
| Atec Spine | Formerly PE-Backed | Carlsbad, CA | 000 | 00000 | 00000000 | 00000 |
| Spinal Elements | Private Equity-Backed | Carlsbad, CA | 000 | 000.00 | 00000000000 | 000.00 |
| Globus Medical | Formerly VC-backed | Audubon, PA | 0000 | 00000 | 000000 - 000 | 00000 |
| Spine Wave | Venture Capital-Backed | Shelton, CT | 00 | 00000 | 00000000000 | 00000 |
Xtant Medical Patents
Xtant Medical Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-11627952-B2 | Surgical retractor | Active | 29-Jun-2020 | 00000000000 | 000 |
| US-20210401423-A1 | Surgical retractor | Active | 29-Jun-2020 | 00000000000 | 0 |
| US-20210298804-A1 | Bone plate system | Active | 26-Mar-2020 | 00000000000 | 0 |
| US-11877779-B2 | Bone plate system | Active | 26-Mar-2020 | 00000000000 | 000 |
| US-20240156498-A1 | Bone plate system | Pending | 26-Mar-2020 | A61B17/8047 | 0 |
Xtant Medical Executive Team (24)
| Name | Title | Board Seat |
|---|---|---|
| Sean Browne | Chief Executive Officer, President & Board Member | |
| Scott Neils | Chief Financial Officer | |
| Mark Schallenberger | Chief Operating Officer, Operations | |
| Kevin Brandt | Chief Commercialization Officer | |
| Jamey Rottman | Vice President, Marketing |
Xtant Medical Board Members (18)
| Name | Representing | Role | Since |
|---|---|---|---|
| John Bakewell | Self | Board Member | 000 0000 |
| Lori Mitchell-Keller | Self | Board Member | 000 0000 |
| Robert Mcnamara | Self | Board Member | 000 0000 |
| Sean Browne | Xtant Medical | Chief Executive Officer, President & Board Member | 000 0000 |
| Stavros Vizirgianakis | Self | Chairman & Board Member | 000 0000 |
Xtant Medical Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Xtant Medical Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Xtant Medical Acquisitions (7)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| RTI Surgical (NanOss Production Operations in Greenville, North Carolina) | 23-Oct-2023 | 0000000000 | 00.000 | Surgical Devices | 0000 0000 |
| Surgalign (Hardware and Biologics Business) | 10-Aug-2023 | 0000000000 | 00.000 | Surgical Devices | 0000 0000 |
| Surgalign (Coflex and Cofix Product Lines) | 28-Feb-2023 | 0000000000 | 0000 | Surgical Devices | 0000 0000 |
| X-Spine Systems | 31-Jul-2015 | 0000000000 | 000.00 | Therapeutic Devices | 000000 00 |
| Robinson Medsurg | 18-Jul-2011 | Merger/Acquisition | 00000 | Distributors (Healthcare) | 000 0000 |
Xtant Medical ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Healthcare
Industry
Rank
Percentile
Medical Devices
Subindustry
Rank
Percentile
Xtant Medical FAQs
-
When was Xtant Medical founded?
Xtant Medical was founded in 1998.
-
Who is the CEO of Xtant Medical?
Sean Browne is the CEO of Xtant Medical.
-
Where is Xtant Medical headquartered?
Xtant Medical is headquartered in Belgrade, MT.
-
What is the size of Xtant Medical?
Xtant Medical has 215 total employees.
-
What industry is Xtant Medical in?
Xtant Medical’s primary industry is Therapeutic Devices.
-
Is Xtant Medical a private or public company?
Xtant Medical is a Public company.
-
What is Xtant Medical’s stock symbol?
The ticker symbol for Xtant Medical is XTNT.
-
What is the current stock price of Xtant Medical?
As of 16-Sep-2024 the stock price of Xtant Medical is $0.60.
-
What is the current market cap of Xtant Medical?
The current market capitalization of Xtant Medical is $82.6M.
-
What is Xtant Medical’s current revenue?
The trailing twelve month revenue for Xtant Medical is $111M.
-
Who are Xtant Medical’s competitors?
Orthofix International, Atec Spine, Spinal Elements, Globus Medical, and Spine Wave are some of the 14 competitors of Xtant Medical.
-
What is Xtant Medical’s annual earnings per share (EPS)?
Xtant Medical’s EPS for 12 months was -$0.02.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
